Evidence map›Paper›PMID 33262946›Full record

ArticleFrontiers in oncology2020

Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia.

Qingqing Zheng, Chuang Jiang, Haiyan Liu, Wenge Hao, Pengfei Wang, Haiying Huang, Ziping Li, Jiabi Qian, Maoxiang Qian, Hui Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Qingqing ZhengDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Chuang JiangShanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Haiyan LiuDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Wenge HaoDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Pengfei WangDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Haiying HuangDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Ziping LiDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Jiabi QianDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Maoxiang QianInstitute of Pediatrics and Department of Hematology and Oncology, Children’s Hospital of Fudan University, the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Hui ZhangDepartment of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Guangzhou Medical University · CNChildren's Hospital of Fudan University · CNGuangzhou Women and Children Medical Center · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute lymphoblast leukemiaFOXO1MRD—minimal residual diseaserelapserisk stratification

Identifiers

PMID33262946
PMCPMC7686545
OpenAlexW3106379001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.